← FDA DRUG APPROVALS

FDA ANDA · ANDA074600

CLOMIPRAMINE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA074600
TYPE
ANDA
ORIGINAL APPROVAL
1996-11-27
LATEST ACTION
2002-09-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CLOMIPRAMINE HYDROCHLORIDEDiscontinued
CLOMIPRAMINE HYDROCHLORIDE 50MG · CAPSULE · ORAL
CLOMIPRAMINE HYDROCHLORIDEDiscontinued
CLOMIPRAMINE HYDROCHLORIDE 75MG · CAPSULE · ORAL
CLOMIPRAMINE HYDROCHLORIDEDiscontinued
CLOMIPRAMINE HYDROCHLORIDE 25MG · CAPSULE · ORAL

Approval history

2002-09-10Labeling · Supplement 5AP
2001-09-28Manufacturing (CMC) · Supplement 4AP
2000-05-18Labeling · Supplement 3AP
1999-08-24Labeling · Supplement 2AP
1998-03-06Labeling · Supplement 1AP
1996-11-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →